Evidence map›Paper›PMID 33244722›Full record

ReviewClinical rheumatology2021

Clinical and ultrasound response to intralesional sodium thiosulfate for the treatment of calcinosis cutis in the setting of systemic sclerosis. A case-based review.

Ana Elísabet López-Sundh, A Quintana-Sancho, C Durán-Vian, L Reguero-DelCura, A F Corrales-Martínez, C Gómez-Fernández, M A González-López

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Clinical rheumatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Calcinosis in dermatomyositis.Current opinion in rheumatology · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Calcinosis in dermatomyositis: Origins and possible therapeutic avenues.Best practice & research. Clinical rheumatology · 2022
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ana Elísabet López-SundhDepartment of Dermatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. alopezsundh@gmail.com.ORCID https://orcid.org/0000-0002-2660-2347
A Quintana-SanchoDepartment of Dermatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
C Durán-VianDepartment of Dermatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
L Reguero-DelCuraDepartment of Dermatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
A F Corrales-MartínezDepartment of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
C Gómez-FernándezDepartment of Dermatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
M A González-LópezDepartment of Dermatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Marqués de Valdecilla University Hospital · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calcinosis cutis (CC) is defined as the deposition of calcium salts on the skin and subcutaneous tissue. It is associated with different conditions, including some autoimmune diseases, and it can generate significant inflammation, pain, and functional impairment. Different therapies have been tried with limited results. Intralesional sodium thiosulfate seems a promising therapeutic option. We report a patient with diffuse systemic sclerosis who presented with two symmetrical plaques on both axillae, which caused pain and skin retraction. The clinical diagnosis was consistent with CC, which was confirmed by skin biopsy and ultrasound. The patient was treated with a 250 mg/ml solution of sodium thiosulfate injected into the plaques. Complete resolution was achieved after three monthly sessions. The only reported adverse effect was a transient burning sensation during the injections. Given its effectiveness and safety, we believe that intralesional sodium thiosulfate could become a valid first-line option for the treatment of CC.

Indexed as

CalcinosisScleroderma, SystemicSkin DiseasesHumansThiosulfatessodium thiosulfateThiosulfatesCalcinosis cutisSodium thiosulfateSystemic sclerosisUltrasound

Identifiers

PMID33244722
OpenAlexW3107832022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.